Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A MacMullan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Arthritis Research & Therapy|May 27, 2010
The meniscus, calcification and osteoarthritis: a pathologic teamPaul A MacMullan, Geraldine M McCarthy
Clinical Rheumatology|September 26, 2014
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritisPaul A MacMullan, Anne M Madigan, Nevin Paul, et al.
Rheumatology (Oxford, England)|November 6, 2012
Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumaticaEoghan M McCarthy, Paul A MacMullan, Shibeb Al-Mudhaffer, et al.
The Journal of Rheumatology|April 3, 2014
Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective studyEoghan M McCarthy, Paul A MacMullan, Shibeb Al-Mudhaffer, et al.
Annals of the Rheumatic Diseases|September 11, 2019
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of goutDavid Bursill, William J Taylor, Robert Terkeltaub, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Arthritis Research & Therapy|May 27, 2010
The meniscus, calcification and osteoarthritis: a pathologic teamPaul A MacMullan, Geraldine M McCarthy
Clinical Rheumatology|September 26, 2014
Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritisPaul A MacMullan, Anne M Madigan, Nevin Paul, et al.
Rheumatology (Oxford, England)|November 6, 2012
Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumaticaEoghan M McCarthy, Paul A MacMullan, Shibeb Al-Mudhaffer, et al.
The Journal of Rheumatology|April 3, 2014
Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective studyEoghan M McCarthy, Paul A MacMullan, Shibeb Al-Mudhaffer, et al.
Annals of the Rheumatic Diseases|September 11, 2019
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of goutDavid Bursill, William J Taylor, Robert Terkeltaub, et al.
Pageof 1